ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 12th, 2015 • Imprimis Pharmaceuticals, Inc. • Pharmaceutical preparations • California
Contract Type FiledNovember 12th, 2015 Company Industry JurisdictionThis ASSET PURCHASE AGREEMENT (the “Agreement”), is made this 23rd day of September, 2015, by and among Thousand Oaks Holding Company, Inc., a Delaware corporation (“Company”), Topical Apothecary Group, LLC, a Pennsylvania limited liability company (“TAG”), Aerosol Science Laboratories, Inc., a California corporation (“ASL”), SinuTopic, Inc., a Delaware corporation (“SD”), Mycotoxins, LLC, a California limited liability company (“MYC” and together with TAG, ASL, and SD, collectively, “Subsidiaries” and each a “Subsidiary”; and together with Company, TAG, ASL, and SD, collectively, “Sellers” and each, individually, a “Seller”), and ImprimisRx PA, Inc., a Delaware corporation (“Buyer”).